COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria-Reference-Cited by-同舟云学术

COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria

Published:2021-05-21 Issue:20 Volume:100 Page:e25456
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Sokol Juraj,Nehaj Frantisek,Mokan Michal,Lisa Lenka,Stasko Jan

Funder

Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR

Vedecká Grantová Agentúra MŠVVaŠ SR a SAV

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference19 articles.

1. Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents;Risitano;Biologics,2008

2. Acute myocardial infarction in a Chinese patient with paroxysmal nocturnal hemoglobinuria: a case report;Li;Medicine (Baltimore),2019

3. Therapeutic challenges in pregnant women with paroxysmal nocturnal hemoglobinuria: a case report;Bastos;Medicine (Baltimore),2018

4. Frequency of paroxysmal nocturnal hemoglobinuria in patients attended in Belém, Pará, Brazil;de Brito Junior;Rev Bras Hematol Hemoter,2011

5. Report of a case of paroxysmal nocturnal hemoglobinuria (PNH) with complex evolution and liver transplant;Alencar;J Bras Patol Med Lab,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feature Paper in Oral Physiology and Pathology;Life;2024-07-19

2. COVID-19 vaccination prevents a more severe course and treatment with complement inhibitors reduce worsening hemolysis during the Omicron pandemic in patients with PNH: a single-center study;Annals of Medicine;2023-12-12

3. The Features of COVID-19’s Course and the Efficacy of the Gam-COVID-Vac Vaccine in Patients with Paroxysmal Nocturnal Hemoglobinuria;Hematology Reports;2023-09-01

4. Severe hemolytic exacerbations of Chinese PNH patients infected SARS‐CoV‐2 Omicron;Immunity, Inflammation and Disease;2023-08

5. Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs;Blood Reviews;2023-03